Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CCRL2 Protein (AA 171-344) (His-IF2DI Tag)

CCRL2 Origin: Human Host: Escherichia coli (E. coli) Recombinant Greater than 90 % by SDS-PAGE gel analyses ELISA, WB
Catalog No. ABIN7122316
  • Target See all CCRL2 Proteins
    CCRL2 (Chemokine (C-C Motif) Receptor-Like 2 (CCRL2))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 171-344
    Origin
    • 3
    • 1
    Human
    Source
    • 2
    • 2
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This CCRL2 protein is labelled with His-IF2DI Tag.
    Application
    ELISA, Western Blotting (WB)
    Purity
    Greater than 90 % by SDS-PAGE gel analyses
    Sterility
    0.2 μm filtered
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in PBS with 5 % trehalose, pH 7.4
    Storage
    4 °C,-20 °C
    Storage Comment
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Expiry Date
    12 months
  • Target
    CCRL2 (Chemokine (C-C Motif) Receptor-Like 2 (CCRL2))
    Alternative Name
    CCRL2 (CCRL2 Products)
    Synonyms
    CCRL2 Protein, ACKR5 Protein, CKRX Protein, CRAM Protein, CRAM-A Protein, CRAM-B Protein, HCR Protein, 1810047I05Rik Protein, Ackr5 Protein, CCR11 Protein, Cmkbr1l2 Protein, E01 Protein, L-CCR Protein, C-C motif chemokine receptor like 2 Protein, chemokine (C-C motif) receptor-like 2 Protein, Ccrl2 Protein, CCRL2 Protein
    Background
    C C chemokine receptor like 2, CCR11, CCR6, CCRL2, Chemokine receptor CCR11, Chemokine receptor X, CKRX, CRAM, CRAM A, CRAM B, FLJ55815, HCR
    Molecular Weight
    41.1 kDa
    UniProt
    O00421
You are here: